Research programme: prophylactic anti-infective vaccines - Hilleman Laboratories

Drug Profile

Research programme: prophylactic anti-infective vaccines - Hilleman Laboratories

Alternative Names: Cholera vaccine - Hilleman Laboratories; ETEC vaccine; HSRV - Hilleman Laboratories; Low-cost men ACYWX conjugate vaccine

Latest Information Update: 07 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MSD Wellcome Trust Hilleman Laboratories
  • Class Bacterial vaccines; Cholera vaccines; Conjugate-vaccines; Escherichia coli vaccines; Meningococcal vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Meningococcal infections
  • Research Escherichia coli infections
  • No development reported Cholera

Most Recent Events

  • 30 Mar 2017 MSD Wellcome Trust Hilleman Laboratories and Institute of Cholera and Enteric Diseases (NICED), India sign a Memorandum of Understanding to jointly develop vaccines for diarrhoeal diseases
  • 16 Jul 2016 No recent reports of development identified for research development in Cholera(Prevention) in India (PO)
  • 10 Apr 2016 Early research in Escherichia coli infections (Prevention) in India (PO) before April 2016 (Hilleman Laboratories website, April 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top